{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:40Z","timestamp":1792787860617,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the provincial project of teaching reform in colleges and universities of Jiangxi Province","award":["JXJG-22-1-60"],"award-info":[{"award-number":["JXJG-22-1-60"]}]},{"name":"Health Commission Science and Technology Plan of Jiangxi Province","award":["202210452"],"award-info":[{"award-number":["202210452"]}]},{"name":"Administration of Traditional Chinese Medicine Science and Technology Plan of Jiangxi Province","award":["2021A060"],"award-info":[{"award-number":["2021A060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to analyze the characteristics of high frame rate contrast-enhanced ultrasound (H-CEUS) in renal lesions and to improve the ability for differential diagnosis of renal tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 140 patients with renal lesions underwent contrast-enhanced ultrasound (CEUS) examination in the First Affiliated Hospital of Nanchang University from July 2022 to July 2023. Based on the tumor pathology and the results of enhanced CT, tumor patients were divided into malignant and benign groups. All subjects were examined using gray-scale ultrasound, conventional contrast-enhanced ultrasound (C-CEUS), and H-CEUS, and their dynamic images were recorded. Two radiologists independently analyzed and recorded the results of ultrasound, C-CEUS, and H-CEUS images and statistically analyzed the features of C-CEUS and H-CEUS images. The independent sample\n                      <jats:italic>t<\/jats:italic>\n                      -test was used to compare the difference in age and maximum diameter of nodules between the benign and malignant groups. The\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      test was used to compare the sex, mode of operation, gray-scale ultrasound characteristics, and enhancement characteristics of the two CEUS modes (enhancement mode, regression mode, enhancement degree, enhancement uniformity, enhancement or not, enhancement direction, post-enhancement boundary and range, and pseudocapsule) between the benign and malignant groups. The difference in vascular morphology of malignant nodules of varying sizes under two angiographic modes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were significant differences in gender (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u200910.408,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), mode of operation (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u200947.089,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), nodule composition (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20097.481,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), nodule echo (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u200920.926,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), necrosis (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u200931.343,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and nodule blood flow (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20099.006,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029) between the benign and malignant groups. There were significant differences in the regression model (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20096.782,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034) and enhancement direction (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u200913.771,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) between the two radiographic techniques in the malignant group. There was a significant difference in the enhancement uniformity between the two CEUS techniques in the benign group (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20098.264,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004). There was a significant difference between the two CEUS techniques in displaying the vascular morphology in the malignant group with the maximum diameter of nodules\u2009\u2264\u20094.0\u00a0cm (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u200911.421,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.022). However, there was no significant difference between the two techniques in the malignant group with the maximum diameter of nodules\u2009&gt;\u20094.0\u00a0cm.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increasing the frame rate of ultrasound images is helpful to accurately display the enhanced features and vascular morphology of renal tumors, especially for malignant tumors with a maximum diameter of \u2264\u20094.0\u00a0cm. Thus, H-CEUS can make up for the limitation of CEUS with regard to the display of vascular morphology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-024-01245-0","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T06:01:45Z","timestamp":1711346505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characteristics of high frame frequency contrast-enhanced ultrasound in renal tumors"],"prefix":"10.1186","volume":"24","author":[{"given":"WeiPing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingLing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"issue":"1","key":"1245_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1148\/radiol.13130161","volume":"271","author":"RG Barr","year":"2014","unstructured":"Barr RG, Peterson C, Hindi A. Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology. 2014;271(1):133\u201342.","journal-title":"Radiology"},{"issue":"4","key":"1245_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s00261-017-1307-0","volume":"43","author":"B Kazmierski","year":"2018","unstructured":"Kazmierski B, Deurdulian C, Tchelepi H, et al. Applications of contrast-enhanced ultrasound in the kidney. Abdom Radiol (NY). 2018;43(4):880\u201398.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"1245_CR3","first-page":"2022","volume":"39","author":"S Bahadoram","year":"2022","unstructured":"Bahadoram S, Davoodi M, Hassanzadeh S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):2022\u2013vol3.","journal-title":"G Ital Nefrol"},{"issue":"12","key":"1245_CR4","doi-asserted-by":"publisher","first-page":"e5059","DOI":"10.1016\/j.urolonc.2015.07.017","volume":"33","author":"BR Winters","year":"2015","unstructured":"Winters BR, Gore JL, Holt SK, et al. Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size. Urol Oncol. 2015;33(12):e5059\u201313.","journal-title":"Urol Oncol"},{"issue":"2","key":"1245_CR5","first-page":"127","volume":"71","author":"GM Pavlakis","year":"2004","unstructured":"Pavlakis GM, Sakorafas GH, Anagnostopoulos GK. Intestinal metastases from renal cell carcinoma: a rare cause of intestinal obstruction and bleeding. Mt Sinai J Med. 2004;71(2):127\u201330.","journal-title":"Mt Sinai J Med"},{"issue":"11","key":"1245_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11934-019-0936-y","volume":"20","author":"MC Olson","year":"2019","unstructured":"Olson MC, Abel EJ, Mankowski Gettle L. Contrast-enhanced Ultrasound in renal imaging and intervention. Curr Urol Rep. 2019;20(11):73.","journal-title":"Curr Urol Rep"},{"issue":"4","key":"1245_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/jum.15762","volume":"41","author":"SE Zeng","year":"2022","unstructured":"Zeng SE, Du MY, Yu Y, et al. Ultrasound, CT, and MR Imaging for Evaluation of Cystic Renal Masses. J Ultrasound Med. 2022;41(4):807\u201319.","journal-title":"J Ultrasound Med"},{"issue":"4","key":"1245_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/jcm11041112","volume":"11","author":"E Roussel","year":"2022","unstructured":"Roussel E, Campi R, Amparore D, On Behalf Of The European Association Of Urology Eau Young Academic Urologists Yau Renal Cancer Working Group, et al. Expanding the role of Ultrasound for the characterization of renal masses. J Clin Med. 2022;11(4):1112.","journal-title":"J Clin Med"},{"issue":"1","key":"1245_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/MNH.0000000000000664","volume":"30","author":"NM Selby","year":"2021","unstructured":"Selby NM, Williams JP, Phillips BE. Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases. Curr Opin Nephrol Hypertens. 2021;30(1):138\u201343.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"1245_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.rcl.2020.05.002","volume":"58","author":"KG King","year":"2020","unstructured":"King KG. Use of contrast Ultrasound for Renal Mass evaluation. Radiol Clin North Am. 2020;58(5):935\u201349.","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"1245_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00261-022-03438-z","volume":"47","author":"A Aggarwal","year":"2022","unstructured":"Aggarwal A, Goswami S, Das CJ. Contrast-enhanced ultrasound of the kidneys: principles and potential applications. Abdom Radiol (NY). 2022;47(4):1369\u201384.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"1245_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/s-0042-104646","volume":"37","author":"J R\u00fcbenthaler","year":"2016","unstructured":"R\u00fcbenthaler J, Bogner F, Reiser M, et al. Contrast-enhanced Ultrasound (CEUS) of the kidneys by using the Bosniak classification. Ultraschall Med. 2016;37(3):234\u201351.","journal-title":"Ultraschall Med"},{"issue":"1","key":"1245_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/CH-152009","volume":"63","author":"R Reimann","year":"2015","unstructured":"Reimann R, R\u00fcbenthaler J, Hristova P, et al. Characterization of histological subtypes of clear cell renal cell carcinoma using contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2015;63(1):77\u201387.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"2","key":"1245_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/CH-152010","volume":"63","author":"J R\u00fcbenthaler","year":"2015","unstructured":"R\u00fcbenthaler J, Reimann R, Hristova P, et al. Parametric imaging of clear cell and papillary renal cell carcinoma using contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2015;63(2):89\u201397.","journal-title":"Clin Hemorheol Microcirc"},{"key":"1245_CR15","doi-asserted-by":"crossref","unstructured":"Liu H et al. Cao Hongli,Chen LinThe quantitative evaluation of contrast-enhanced ultrasound in the differentiation of small renal cell carcinoma subtypes and angiomyolipoma.[J].Quant Imaging Med Surg, 2022;12(1): 106\u2013118.","DOI":"10.21037\/qims-21-248"},{"issue":"1","key":"1245_CR16","first-page":"51","volume":"57","author":"C Nicolau","year":"2021","unstructured":"Nicolau C, Antunes N, Pa\u00f1o B, Sebastia C. Imaging characterization of renal masses. Med (Kaunas). 2021;57(1):51.","journal-title":"Med (Kaunas)"},{"key":"1245_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40477-022-00724-w","volume":"26","author":"F Giangregorio","year":"2023","unstructured":"Giangregorio F, Garolfi M, Mosconi E, et al. High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients[. J] J Ultrasound. 2023;26:71\u20139.","journal-title":"J] J Ultrasound"},{"issue":"9","key":"1245_CR18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s11547-023-01679-6","volume":"128","author":"R Cannella","year":"2023","unstructured":"Cannella R, Pilato G, Mazzola M, et al. New microvascular ultrasound techniques: abdominal applications. Radiol Med. 2023;128(9):1023\u201334.","journal-title":"Radiol Med"},{"issue":"1","key":"1245_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00261-021-03295-2","volume":"47","author":"RG Barr","year":"2022","unstructured":"Barr RG. Use of lumason\/sonovue in contrast-enhanced ultrasound of the kidney for characterization of renal masses-a meta-analysis. Abdom Radiol (NY). 2022;47(1):272\u201387.","journal-title":"Abdom Radiol (NY)"},{"issue":"9","key":"1245_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4111\/kju.2014.55.9.587","volume":"55","author":"TH Oh","year":"2014","unstructured":"Oh TH, Lee YH, Seo IY. Diagnostic efficacy of contrast-enhanced ultrasound for small renal masses. Korean J Urol. 2014;55(9):587\u201392.","journal-title":"Korean J Urol"},{"issue":"5","key":"1245_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.rcl.2022.04.006","volume":"60","author":"JH Squires","year":"2022","unstructured":"Squires JH, Fetzer DT, Dillman JR. Practical contrast enhanced liver ultrasound. Radiol Clin North Am. 2022;60(5):717\u201330.","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"1245_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11934-013-0309-x","volume":"14","author":"S Houtzager","year":"2013","unstructured":"Houtzager S, Wijkstra H, de la Rosette JJ, et al. Evaluation of renal masses with contrast-enhanced ultrasound. Curr Urol Rep. 2013;14(2):116\u201323.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"1245_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.14218\/JCTH.2020.00172","volume":"10","author":"Fei Xiang,Han Peng,Jiang Bo","year":"2022","unstructured":"Fei Xiang,Han Peng,Jiang Bo. High Frame rate contrast-enhanced Ultrasound helps Differentiate Malignant and Benign Focal Liver lesions.[J]. J Clin Transl Hepatol. 2022;10(1):26\u201333.","journal-title":"J Clin Transl Hepatol"},{"key":"1245_CR24","doi-asserted-by":"publisher","unstructured":"Huang CZW,Gong, Ping et al. Super-resolution ultrasound localization microscopy based on a high frame-rate clinical ultrasound scanner: an in-human feasibility study.[J].Phys Med Biol, 2021;66(8):https:\/\/doi.org\/10.1088\/1361-6560\/abef45.","DOI":"10.1088\/1361-6560\/abef45"},{"key":"1245_CR25","doi-asserted-by":"crossref","unstructured":"Lianhua FXLN et al. Value of high frame rate contrast-enhanced ultrasound in distinguishing gallbladder adenoma from cholesterol polyp lesion.[J].Eur Radiol, 2021;31(9): 6717\u20136725.","DOI":"10.1007\/s00330-021-07730-2"},{"key":"1245_CR26","doi-asserted-by":"crossref","unstructured":"van Helvert Majorie,Engelhard Stefan,Voorneveld Jason, et al. High-frame-rate contrast-enhanced ultrasound particle image velocimetry in patients with a stented superficial femoral artery: a feasibility study.[J].Eur Radiol Exp, 2022;6(1): 32.","DOI":"10.1186\/s41747-022-00278-w"},{"issue":"3","key":"1245_CR27","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/cam4.5101","volume":"12","author":"J Zhu","year":"2023","unstructured":"Zhu J, Li N, Zhao P, et al. Contrast-enhanced ultrasound (CEUS) of benign and malignant renal tumors: distinguishing CEUS features differ with tumor size. Cancer Med. 2023;12(3):2551\u20139.","journal-title":"Cancer Med"},{"issue":"1","key":"1245_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejrad.2008.09.030","volume":"73","author":"J Jiang","year":"2010","unstructured":"Jiang J, Chen Y, Zhou Y, et al. Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol. 2010;73(1):162\u20137.","journal-title":"Eur J Radiol"},{"issue":"23","key":"1245_CR29","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1002\/cam4.4365","volume":"10","author":"LYK Yang","year":"2021","unstructured":"Yang LYK,,Jincun Z, et al. Characteristics of contrast-enhanced ultrasound for diagnosis of solid clear cell renal cell carcinomas\u2009\u2264\u20094\u00a0cm: a meta-analysis. [J]. Cancer Med. 2021;10(23):8288\u201399.","journal-title":"Cancer Med"},{"issue":"11","key":"1245_CR30","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.ultrasmedbio.2020.07.022","volume":"46","author":"HJ Vos","year":"2020","unstructured":"Vos HJ, Voorneveld JD, Groot Jebbink E, et al. Contrast-enhanced high-frame-rate Ultrasound Imaging of Flow patterns in Cardiac Chambers and Deep vessels. Ultrasound Med Biol. 2020;46(11):2875\u201390.","journal-title":"Ultrasound Med Biol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01245-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T06:03:20Z","timestamp":1711346600000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01245-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01245-0","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"1 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee of first affiliated Hospital of Nanchang University(IIT2023174), and Informed consent was obtained from all participants of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No animals were used in this research. All the human procedures used were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013(\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"NA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}